Eye Support
Eye Support, licence 80066461: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Nutragenius Inc.
- NPN or DIN-HM
- 80066461
- Status
- Inactive licence
- Licence date
- 18 January 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 200 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : bactéries, levures | 30.0 mg | Not calculated |
| (E)-5-(p-hydroxystyryl)resorcinol Source : Vitis vinifera - Fruit | 5.0 mg | Not calculated |
| Vitis vinifera L. Source : Graine(s) Potency : 85.0 % Oligomeric proanthocyanidins | 60.0 mg | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone Source : Vaccinium myrtillus - Fruit | 80.0 mg | Not calculated |
| Vitamine C Source : Acide ascorbique | 100.0 mg | 200,000 µg |
| Vaccinium myrtillus Source : Fruit Extraction ratio : 40:1 Dry plant equivalent : 4000 mg | 100.0 mg | Not calculated |
| Vaccinium angustifolium Source : Fruit Extraction ratio : 20:1 Dry plant equivalent : 200 mg | 10.0 mg | Not calculated |
| Tagetes erecta L. Source : Marigold flower Potency : 6.0 mg Lutein | 120.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, chlorophylle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Source of antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80066461
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.